Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin in Prediabetes
NCT02700334Phase 4Completed
- Sponsor
- Universidad de Guadalajara
- Start
- Oct 2016
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dapagliflozin in prediabetes, sponsored by Universidad de Guadalajara. Started Oct 2016; status: completed.
02
Drugs
dapagliflozin
03
Conditions
prediabetes
Beyond the preview
Go deeper on NCT02700334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02700334.